Skip to main content

Novo Nordisk A/S B New(NONOF)
OTC US

Today's Change
Delayed Last Update

Novo Nordisk A/S B New

Sectors & Indices

Sector
Industry
Employees

    Profile

    Novo-Nordisk A/S was incorporated on 28th November, 1931 in Denmark. It is a healthcare company that is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments: diabetes care and biopharmaceuticals. The diabetes care segment covers insulins, GLP-1, other protein-related products which include glucagon, protein-related delivery systems and needles, obesity and oral antidiabetic drugs. The biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy, hormone replacement therapy and inflammation.

    Key Executives

    NameTitle
    Information not available.

    More from The Globe

    The most oversold and overbought stocks on the TSX
    The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
    Monday’s analyst upgrades and downgrades
    A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
    opinion
    Why are Canadian bank valuations so low?
    Tom Bradley
    number cruncher
    Eleven U.S. semiconductor stocks showing strength
    For Number Cruncher column in Globe Investor/ROB only.
    Wednesday’s analyst upgrades and downgrades
    An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
    Bullish on Archer-Daniels-Midland Co.
    Monica Rizk
    Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
    In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.
    number cruncher
    Eight telecom stocks to watch during volatile times
    For Number Cruncher column in Globe Investor/ROB only.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.